Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticardiolipin Autoantibodies as Useful Biomarker for the Prediction of Mortality in Septic Patients

NCT04685278 is registered in ClinicalTrials.gov with Military Hospital of Tunis as lead sponsor.

NCT NCT04685278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04685278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticardiolipin Autoantibodies as Useful Biomarker for the Prediction of Mortality in Septic Patients
Lead sponsor
Military Hospital of Tunis
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2020
Completion date
February 15, 2021
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

morality